Exercise and Protein Efficiency in T2D
Recruiting now · Not applicable
Conditions studied: Type 2 Diabetes, Control Condition
In brief
In this randomized controlled trial, 30 older adults (aged\> 65 years; 15 with T2D, 15 controls) will participate in a 12-week progressive exercise training program. They will undergo pre- and post-testing that includes body composition measures; oral glucose tolerance testing; cardiovascular fitness and muscle performance testing; dietary protein efficiency assessed using the indicator amino acid oxidation (IAAO) method; and a gut microbiota trial. The dietary protein efficiency trial will include repeated ingestion of crystallized amino acids (drink) containing stable isotopes, urine samples, and breath samples. The gut microbiome trial will consist of a single ingestion of a Mediterranean-based modeled meal enriched with 13C-phenylalanine (in the drink) and repeated blood draws. Participants will also be asked to give a fecal sample after the gut microbiome trial.
Key facts
- Study ID
- NCT07477067
- Run by
- University of Illinois at Urbana-Champaign
- People needed
- 30
- Starts
- 2026-02-09
- Expected to finish
- 2028-07-01
- Last updated by the study team
- 2026-04-29
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- At least 65 years old
- Body mass index: 25-40 kg/m\^2
- Female: Waist to hip ratio >0.8
- Male: Waist to hip ratio >1.0
- Free from structured exercise during the prior 6 months (mo) weight stable for the prior 6 months
- T2D group:
- Diagnosed by a physician with elevated glycosylated hemoglobin (HbA1c) >6.5%
- Control group:
- Normoglycemic with HbA1c levels not exceeding 5.6% and fasting blood glucose levels below or equal to 99 mg/dL (5.5mmol)
You may not qualify if…
- Uncontrolled diabetes (evidence of HbA1c > 10%, prescription of insulin)
- Diagnoses of diabetic neuropathy or failing diabetic neuropathy screening
- Statins
- Peripheral edema Consumption of ergogenic-levels of dietary supplements that may affect muscle mass (e.g., creatine, HMB), insulin-like substances, or anabolic/catabolic pro-hormones (e.g., DHEA) within 6 weeks prior to participation.
- Untreated hypothyroidism, epilepsy, medications that affect vasoactivity, possibility of pregnancy, and any neurological, cardiovascular, or musculoskeletal disease that precludes exercise testing.
Where it is running
- Freer Hall - University of Illinois — Urbana, Illinois, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.